Blood clot-targeted nanoparticles
CA 2491758 A1 · Owner: Wickline, Samuel A. · Inventors: Lanza, Gregory; Wickline, Samuel A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Emulsions comprising nanoparticles formed from high boiling perfluorochemical substances, said particles coated with a lipid/surfactant coating are made target-specific by directly coupling said nanoparticles to a targeting ligand. The nanoparticles may further include biologically active agents radionuclides, and/or other imaging agents and are used to image and/or lyse , blood clots in human subjects.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 20, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 20, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 20, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.